Osterloh, Ian,Wicker, Pierre,Braeckman, Rene,Soni, Paresh,Rowe, Jonathan
申请号：
NZ75781511
公开号：
NZ757815A
申请日:
2011.11.28
申请国别(地区):
NZ
年份:
2020
代理人:
摘要：
Disclosed is the use of eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA) in the manufacture of a medicament to treat or prevent a cardiovascular-related disease, without inducing eructation, in a subject identified as being allergic to or hypersensitive to fish and as having or as being at risk for developing a cardiovascular-related disease, wherein said medicament contains substantially no proteins.
